Consolidative allogeneic HCT vs. a watch-and-wait approach for B-cell acute lymphoblastic leukemia patients with early loss of B-cell aplasia after CAR T-cell therapy.

IF 5.1 2区医学 Q1 HEMATOLOGY

Bone Marrow Transplantation Pub Date : 2026-09-29 DOI:10.1038/s41409-026-03057-y

Sergi Camarillas, Anna Alonso-Saladrigues, Víctor Navarro, Júlia Marsal, Águeda Molinos, Javier Delgado, Blanca Herrero, Alex Rampotas, Claire Roddie, Veit Bücklein, Marion Subklewe, Mario Sánchez-Salinas, Berta González-Martínez, Ana África Martin, Anna Torrent, Antonio Pérez-Martínez, Gloria Iacoboni, Susana Rives, Pere Barba

引用次数: 0

查看原文本刊更多论文

在CAR - t细胞治疗后早期丧失b细胞发育不全的b细胞急性淋巴细胞白血病患者中，巩固性同种异体HCT vs.观察等待方法

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Bone Marrow Transplantation 医学-免疫学

CiteScore

8.40

自引率

8.30%

发文量

337

审稿时长

6 months

期刊介绍： Bone Marrow Transplantation publishes high quality, peer reviewed original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation. The broad scope of the journal thus encompasses topics such as stem cell biology, e.g., kinetics and cytokine control, transplantation immunology e.g., HLA and matching techniques, translational research, and clinical results of specific transplant protocols. Bone Marrow Transplantation publishes 24 issues a year.